Cite Filings / MYGN / 0001193125-20-269804
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEFA14A

Proxy Materials

MYRIAD GENETICS INC · Filed 2020-10-15 · Acc 0001193125-20-269804

Documents 1

  • DEFA14A Proxy Materials , d108994ddefa14a.htm

Around this filing

  • 2021-04-15 DEFA14A Proxy Materials
  • 2020-10-15 DEFA14A Proxy Materials
  • 2020-10-15 8-K Executive or director change · Bylaws or fiscal year change · Other events
  • 2020-10-15 DEFA14A Proxy Materials
  • 2020-10-15 DEF 14A Proxy Statement
  • 2020-10-13 4 EVP Strategy and Innovation acquired 21,730 shares (grant or award)
  • 2020-10-13 4 E.V.P., General Counsel acquired 29,784 shares (grant or award)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d108994ddefa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…